51456-2 |
Filaria Ab.IgG2 |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Filaria IgG2 Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51456-2 |
|
|
|
|
Both |
|
|
|
0 |
Filaria IgG2 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Filarial; Filariasis; ID; Infectious Disease; InfectiousDisease; Microbiology; Microfilaria; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
51457-0 |
Filaria Ab.IgG3 |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Filaria IgG3 Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51457-0 |
|
|
|
|
Both |
|
|
|
0 |
Filaria IgG3 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Filarial; Filariasis; ID; Infectious Disease; InfectiousDisease; Microbiology; Microfilaria; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
51458-8 |
Hepatitis D virus Ab.IgG |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Hepatitis D virus IgG Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51458-8 |
|
|
|
|
Both |
|
|
|
0 |
HDV IgG Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Delta hepatitis; Dextro; HDV; HDVAB; Hep; Hep D; Hep Delta; Hepatis; Hepatit; Hepatitis delta virus; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
51459-6 |
Hepatitis E virus Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Hepatitis E virus Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51459-6 |
|
|
|
|
Both |
|
|
|
0 |
HEV Ab Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Hep; Hep E; Hepatis; Hepatit; HEV; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
5146-6 |
Echovirus 9 Ab.Neut |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Echovirus 9 neutralizing antibody [Titer] in Serum by Neutralization test |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5146-6 |
|
Neut |
|
|
Both |
|
|
|
0 |
ECV9 NAb Titr Ser Nt |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 9; ECV; ECV9; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; |
0 |
51460-4 |
Influenza virus A H16 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Influenza virus A H16 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51460-4 |
|
|
|
|
Both |
|
|
|
0 |
FLUAV H16 Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Avian influenza; Bird flu; Dilution factor; Dilution Factor (Titer); FLUA; FLUAV; FLUAV H16; FLUV; Fowl plague; ID; Infectious Disease; InfectiousDisease; Influ; Influenza A; Influenza A virus; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
51461-2 |
Listeria sp Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Listeria sp Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51461-2 |
|
|
|
|
Both |
|
|
|
0 |
Listeria Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Listeriosis; Microbiology; Point in time; Random; Serum; SmQn; species; spp; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
51462-0 |
Onchocerca sp Ab.IgG2 |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Onchocerca sp IgG2 Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51462-0 |
|
|
|
|
Both |
|
|
|
0 |
Onchocerca IgG2 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Filariasis; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; River blindness; Serum; species; spp; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
51463-8 |
Onchocerca sp Ab.IgG3 |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Onchocerca sp IgG3 Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51463-8 |
|
|
|
|
Both |
|
|
|
0 |
Onchocerca IgG3 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Filariasis; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; River blindness; Serum; species; spp; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
51464-6 |
Onchocerca sp Ab.IgG4 |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Onchocerca sp IgG4 Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51464-6 |
|
|
|
|
Both |
|
|
|
0 |
Onchocerca IgG4 Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Filariasis; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; River blindness; Serum; species; spp; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
51465-3 |
Paragonimus sp Ab |
Titr |
Plr fld |
Pt |
SemiQn |
|
|
ACTIVE |
Paragonimus sp Ab [Titer] in Pleural fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51465-3 |
|
|
|
|
Both |
|
|
|
0 |
Paragonimus Ab Titr Plr |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Lung; Microbiology; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; SmQn; species; spp; thoracentesis fluid; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
51466-1 |
Parainfluenza virus 1+2+3 Ab |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Parainfluenza virus 1+2+3 Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51466-1 |
|
|
|
|
Both |
|
|
|
0 |
HPIV1+2+3 Ab Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); HPIV; HPIV1; HPIV1+2+3; Human respirovirus 1; i; ID; II; III; Infectious Disease; InfectiousDisease; Microbiology; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PI1; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
51467-9 |
Plasmodium falciparum Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Plasmodium falciparum IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51467-9 |
|
|
|
|
Both |
|
|
|
0 |
P falciparum IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Malaria; Malarial; Microbiology; P falciparum; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
51468-7 |
Plasmodium ovale Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Plasmodium ovale IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51468-7 |
|
|
|
|
Both |
|
|
|
0 |
P ovale IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Malaria; Malarial; Microbiology; P ovale; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
51469-5 |
Plasmodium vivax Ab.IgG |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Plasmodium vivax IgG Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51469-5 |
|
|
|
|
Both |
|
|
|
0 |
P vivax IgG Titr Ser |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Malaria; Malarial; Microbiology; P vivax; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
5147-4 |
Echovirus 9 Ab |
Titr |
Ser |
Pt |
SemiQn |
Comp fix |
|
ACTIVE |
Echovirus 9 Ab [Titer] in Serum by Complement fixation |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
5147-4 |
|
Comp fix |
|
|
Both |
|
|
|
0 |
ECV9 Ab Titr Ser CF |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; CF; Comp fixation; Compfix; Complement fixation; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 9; ECV; ECV9; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
51470-3 |
Satratoxin Ab.IgM |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Satratoxin IgM Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51470-3 |
|
|
|
|
Both |
|
|
|
0 |
Satratoxin IgM Ser-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Immune globulin M; Immunoglobulin M; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
51471-1 |
Sporothrix schenckii Ab |
PrThr |
CSF |
Pt |
Ord |
|
|
ACTIVE |
Sporothrix schenckii Ab [Presence] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51471-1 |
|
|
|
|
Both |
|
|
|
0 |
S schenckii Ab CSF Ql |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; S schenckii; Screen; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Sporotrichosis |
2.56 |
2.22 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
51472-9 |
Streptococcus pneumoniae capsular polysaccharide Ab.IgG |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Streptococcus pneumoniae capsular polysaccharide IgG Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
51472-9 |
|
|
|
|
Both |
|
|
|
0 |
S pneum CPS IgG Ser-mCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Capsule; ID; Immune globulin G; Immunoglobulin G; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum CPS; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; Streptococcus pneumoniae CPS |
2.34 |
2.22 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
51473-7 |
Streptococcus pneumoniae capsular polysaccharide Ab.IgG2 |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Streptococcus pneumoniae capsular polysaccharide IgG2 Ab [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
ug/mL |
|
|
|
|
|
|
MICRO |
|
51473-7 |
|
|
|
|
Both |
|
|
|
0 |
S pneum CPS IgG2 Ser-mCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Capsule; ID; Infectious Disease; InfectiousDisease; Level; Mass concentration; Microbiology; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; QNT; Quan; Quant; Quantitative; Random; S pneum CPS; S pneumo; S pneumoniae; Serum; Spn; SR; Strep; Strept; Streptococcus pneumoniae CPS |
2.34 |
2.22 |
|
|
|
|
|
|
|
ug/mL |
|
|
|
0 |
51474-5 |
Treponema pallidum Ab |
ACnc |
CSF |
Pt |
Qn |
|
|
ACTIVE |
Treponema pallidum Ab [Units/volume] in Cerebral spinal fluid |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51474-5 |
|
|
|
|
Both |
|
|
|
0 |
T pallidum Ab CSF-aCnc |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; QNT; Quan; Quant; Quantitative; Random; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; T pallidum; Treponemal |
2.69 |
2.22 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
51475-2 |
Treponema pallidum Ab |
Titr |
CSF |
Pt |
SemiQn |
|
|
ACTIVE |
Treponema pallidum Ab [Titer] in Cerebral spinal fluid |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
51475-2 |
|
|
|
|
Both |
|
|
|
0 |
T pallidum Ab Titr CSF |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Cerebral spinal fluid; Cerebrospinal Fl; Dilution factor; Dilution Factor (Titer); ID; Infectious Disease; InfectiousDisease; Microbiology; Neuro; Neurology; Point in time; Random; SmQn; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Syphilis; T pallidum; Titer; Titered; Titre; Treponemal; Ttr |
2.75 |
2.22 |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
51476-0 |
ABCB4 gene targeted mutation analysis |
Prid |
Bld/Tiss |
Pt |
Nom |
Molgen |
|
ACTIVE |
ABCB4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH.MUT |
|
51476-0 |
|
Molgen |
|
|
Both |
|
|
|
0 |
ABCB4 gene Mut Anl Bld/T |
|
|
|
N |
|
ABC21; ATP-binding cassette, sub-family B (MDR/TAP), member 4; Blood; GBD1; Genetics; Heredity; Heritable; ICP3; Identity or presence; Inherited; MDR2; MDR2/3; MDR3; Molecular genetics; Molecular pathology; MOLPATH; MOLPATH.MUTATIONS; Mut; Mut Anl; Mutations; Nominal; PCR; PFIC3; PFIC-3; PGY3; Point in time; Random; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.63 |
2.22 |
|
|
|
|
|
|
|
|
|
|
Based on LOINC Committee review (June 2016), "targeted" was added to the Component to clarify that this test is looking for a specific set of mutations as described in the LOINC User Guide under the Molecular Genetics section. |
0 |
51477-8 |
Coccidioides sp Ab.IgM |
PrThr |
XXX |
Pt |
Ord |
Immune diffusion |
|
ACTIVE |
Coccidioides sp IgM Ab [Presence] in Specimen by Immune diffusion (ID) |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
51477-8 |
|
Immune diffusion |
|
|
Both |
|
|
|
0 |
Coccidioides IgM Spec Ql ID |
|
|
|
N |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Coccidiodes; ID; Imm; Immune globulin M; Immunodiff; Immunodiffusion; Immunoglobulin M; Imun; Imune; Infectious Disease; InfectiousDisease; Microbiology; Misc; Miscellaneous; Ordinal; Other; Point in time; PR; QL; Qual; Qualitative; Random; San Joaquin Valley fever; Screen; Spec; species; spp; To be specified in another part of the message; Unspecified; Valley fever |
2.69 |
2.22 |
|
|
|
|
|
|
|
|
|
|
The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
51478-6 |
Mucus |
NCnc |
Urine |
Pt |
Qn |
Automated count |
|
ACTIVE |
Mucus [#/volume] in Urine by Automated count |
|
MIN |
DefinitionDescription |
|
|
/uL |
|
|
|
|
|
|
UA |
|
51478-6 |
|
Automated count |
|
|
Observation |
|
|
|
0 |
Mucous Threads # Ur Auto |
|
|
|
N |
|
#; ABS; absolute; absolutes; Auto; Automated detection; Cnt; Count; Count/volume; CT; Elec; Elect; Electr; Mucous; Mucous Threads; Number concentration; Number Concentration (count/vol); Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; URINALYSIS; Urn |
2.73 |
2.22 |
|
|
|
|
|
|
|
/uL |
|
|
|
0 |